Bolt Biotherapeutics chief medical officer Edith Perez joins fellow cancer researchers in Stand Up to Cancer's new PSA.
April 13, 2023 02:42 PM EDTUpdated April 17, 07:47 PM
Pharma
Marketing

Biotech and can­cer cen­ter re­searchers star in Stand Up To Can­cer’s lat­est com­mer­cial

Beth Snyder Bulik

Senior Editor

Stand Up To Can­cer’s newest pub­lic ser­vice an­nounce­ment puts the spot­light on can­cer re­searchers, in­clud­ing one from Bolt Bio­ther­a­peu­tics.

Bolt’s chief med­ical of­fi­cer Edith Perez …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

A service from the Financial Times